ÉîÒ¹ÑÇÖÞ¸£Àû¾Ã¾Ã and media
Caroline Joyce presents at the 11th European Organisation for Treatment of Trophoblastic Diseases Meeting in Warsaw
Caroline Joyce, Clinical Biochemist and PhD Student, recently presented her work on the use of capillary blood collection for human chorionic gonadotrophin (hCG) analysis in early pregnancy at the 11th European Organisation for Treatment of Trophoblastic Diseases (EOTTD) Meeting.
The meeting was hosted at the Medical ÉîÒ¹ÑÇÖÞ¸£Àû¾Ã¾Ã of Warsaw from 11-12 May 2023 and was attended by clinical oncologists, gynaecologists, biochemists and specialist nurses working with this rare disease.
The pregnancy hormone hCG is currently used as a biomarker for Gestational Trophoblastic Disease (GTD) (also known as molar pregnancy) during monitoring and treatment. Through her PhD studies, Caroline aims to identify more sensitive biomarkers for GTD to allow earlier detection of disease recurrence and progression to malignant diseases.
Caroline’s PhD is funded by the Irish Research Council: Employment-Based Programme, in partnership with HSE South. It is supervised by , Dr John Coulter (Department of Obstetrics & Gynaecology, Cork ÉîÒ¹ÑÇÖÞ¸£Àû¾Ã¾Ã Maternity Hospital) and Professor Tommie McCarthy (School of Biochemistry & Cell Biology, UCC).